<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04095130</url>
  </required_header>
  <id_info>
    <org_study_id>ChariteU-ECRC-TSS1</org_study_id>
    <nct_id>NCT04095130</nct_id>
  </id_info>
  <brief_title>Tissue Sodium in Patients With Psoriasis</brief_title>
  <acronym>TSS1</acronym>
  <official_title>Tissue Sodium Accumulation in Patients With Psoriasis: a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Heart Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sodium can be buffered in the skin, which mechanism is altered during aging and in certain
      diseases such as hypertension. High salt environment can promote autoimmunity by expanding
      pathogenic IL-17 producing T helper (Th17) cells. Psoriasis is a relapsing and remitting
      inflammatory autoimmune disease affecting the skin and joints and involves proinflammatory
      Th17 cells. Here we tested the hypothesis if psoriatic skin has a higher sodium content in
      humans.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The cytokine interleukin-17A (IL-17A) is a crucial player in the pathogenesis of the
      autoimmune disease of psoriasis. This neutrophil recruiting cytokine is produced by IL-17A
      producing CD4+ T cells (Th17) and gamma/delta T cells of the skin and evokes an inflammation
      circuit finally leading to the classical clinical picture of psoriasis with hyper- and
      parakeratosis, erythema, scaling and neutrophil abscess formation.

      Besides genetic factors, lifestyle factors are relevant and decide if an autoimmune disease
      becomes manifest. It was shown previously that increased salt (sodium chloride, NaCl)
      concentrations boost the induction of murine and human Th17 cells. However, more - and also
      clinical - studies are needed to understand the correlation between salt content and IL-17A
      in autoimmune diseases.

      This study investigates the hypothesis if skin sodium content in human psoriasis is increased
      in order to get further insight into the IL-17A-salt-interplay.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2015</start_date>
  <completion_date type="Actual">September 17, 2019</completion_date>
  <primary_completion_date type="Actual">March 16, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Non-invasive sodium measurement in the skin</measure>
    <time_frame>4 years</time_frame>
    <description>Sodium measured in the skin by 23Na-MRI is higher in psoriasis patients vs. matched healthy individuals.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">56</enrollment>
  <condition>Psoriasis Vulgaris</condition>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Healthy subjects</arm_group_label>
    <description>those without a condition</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Psoriasis patients</arm_group_label>
    <description>those with a condition</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>23Na Magnetic resonance imaging</intervention_name>
    <description>Measurement of skin sodium content by non-invasive 23Na Magnetic resonance imaging.</description>
    <arm_group_label>Healthy subjects</arm_group_label>
    <arm_group_label>Psoriasis patients</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      human peripheral blood mononuclear cell (PBMC)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy patients recruited locally (invitation to volunteer sent to workers of the Charié
        University Clinic and the Max Delbrück Center for Molecular Medicine).

        Psoriasis patients are recruited who are treated at the Department of Dermatology,
        Venerology and Allergology, Charité Medical Faculty, Berlin, Germany, Immanuel Krankenhaus
        Berlin, Medical Centre for Rheumatology and Clinical Immunology, Berlin, Germany and the
        Helios Clinic Berlin-Buch, Berlin, Germany.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age: 18-80

          -  Body mass index (BMI) 18.5- 40 kg/m2

          -  Glomerular filtration rate &gt;60 ml/min/1.73m2

        Exclusion Criteria:

          -  Diagnosed or treated hypertension and/or blood pressure above 140/90 at screening

          -  Palpable peripheral oedema during phyisical examination at screening

          -  Any type of diabetes mellitus and/or HgbA1c&gt;6.5% at screening

          -  Subjects with a thyroid-stimulating hormone &gt;4.2 mU/L at screening

          -  Psoriasis patients treated with systemic corticosteroids, chemotherapy agent
             (methothrexate) or with any kind of biologics/biosimilars

          -  Subjects with acute disease

          -  Pregnant or lactating women

          -  Metal or medical device implant in the body

          -  Tattoo on the lower extremities

          -  Subjects with a history of drug or alcohol abuse

          -  Subjects who are legal incapacitated or their circumstances do not enable the patient
             to fully understand the nature, significance and scope of this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Experimental and Clinical Research Center, Clinical Research Unit</name>
      <address>
        <city>Berlin</city>
        <zip>13125</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Kopp C, Linz P, Dahlmann A, Hammon M, Jantsch J, Müller DN, Schmieder RE, Cavallaro A, Eckardt KU, Uder M, Luft FC, Titze J. 23Na magnetic resonance imaging-determined tissue sodium in healthy subjects and hypertensive patients. Hypertension. 2013 Mar;61(3):635-40. doi: 10.1161/HYPERTENSIONAHA.111.00566. Epub 2013 Jan 21.</citation>
    <PMID>23339169</PMID>
  </reference>
  <reference>
    <citation>Kleinewietfeld M, Manzel A, Titze J, Kvakan H, Yosef N, Linker RA, Muller DN, Hafler DA. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature. 2013 Apr 25;496(7446):518-22. doi: 10.1038/nature11868. Epub 2013 Mar 6.</citation>
    <PMID>23467095</PMID>
  </reference>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 17, 2019</study_first_submitted>
  <study_first_submitted_qc>September 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 19, 2019</study_first_posted>
  <last_update_submitted>September 18, 2019</last_update_submitted>
  <last_update_submitted_qc>September 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Dr. Lajos Marko</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Psoriasis</keyword>
  <keyword>Sodium</keyword>
  <keyword>Skin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psoriasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Planned to share all IPD that underlie results in a publication.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

